NEW YORK, August 1, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Cognex Corporation (NASDAQ: CGNX), Garmin Ltd. (NASDAQ: GRMN), Trimble Navigation Limited (NASDAQ: TRMB), FEI Company (NASDAQ: FEIC) and Cepheid (NASDAQ: CPHD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5331-100free.
Cognex Corporation Research Reports
On July 28, 2014, Cognex Corp. (Cognex) reported its Q2 2014 financial results with revenue growth of 25.8% YoY to $108.8 million. Net income grew 54.3% YoY to $25.9 million. Diluted EPS was $0.29 compared to $0.19 in Q2 2013. Robert J. Willett, CEO of Cognex said, "Our second quarter performance was outstanding. The strong upward momentum in our business is driven by past investments we made in our technology and sales team. It's gratifying to see our hard work deliver these great financial results. Even more exciting is the substantial growth that we expect to report for Q3." The Company now anticipates Q3 2014 revenues to be in the range of $165 million to $170 million. The full research reports on Cognex are available to download free of charge at:
http://www.analystsreview.com/Aug-01-2014/CGNX/report.pdf
Garmin Ltd. Research Reports
On July 23, 2014, Garmin International Inc., a business unit of Garmin Ltd. (Garmin) announced that it has introduced a new 7-inch G3X Touch display option for experimental amateur-built and light sport aircraft. The Company informed that the 7-inch G3X Touch display also features a robust, infrared touchscreen display, which utilizes Garmin's industry-leading experience in glass cockpit technology. Carl Wolf, Vice President of Aviation Sales and Marketing commented, "Customization and flexibility are key when designing an aircraft panel and the new 7-inch G3X Touch display offers just that - the option to tailor the instrument panel to the needs of any homebuilder, while equipping them with an intuitive touchscreen-based flight display with incredible capability." The full research reports on Garmin are available to download free of charge at:
http://www.analystsreview.com/Aug-01-2014/GRMN/report.pdf
Trimble Navigation Limited Research Reports
On July 14, 2014, Trimble Navigation Limited (Trimble) announced the acquisition of the assets of privately-held The Omega Group, based in San Diego, California. According to the Company, The Omega Group is a leading provider of cloud-based and on-premise operational performance support software that integrates mapping, analytics, intelligence and mobile technologies, allowing public safety agencies to optimize patrol strategies and daily field work. Trimble added that the acquisition adds enterprise Geographic Information System (GIS), big data/analytics and mobility-driven capabilities to its portfolio of traffic, crash reporting and crash/crime scene reconstruction solutions. Bill Martin, General Manager of Trimble's Public Safety division said, "By expanding our public safety portfolio to include The Omega Group's data intelligence and analysis solutions, we are offering a set of comprehensive tools to transform the way law enforcement, fire and EMS work with data-driven approaches to enhance safety in their communities." The full research reports on Trimble are available to download freeof charge at:
http://www.analystsreview.com/Aug-01-2014/TRMB/report.pdf
FEI Company Research Reports
On July 28, 2014, FEI Company (FEI) announced the addition of two new products for cryo-electron microscopy applications: a new phase plate solution and the Titan Halo' transmission electron microscope (TEM). According to the Company, the phase plate is a stable, durable solution to increase the contrast of sensitive biological samples and is available on most TEM platforms from FEI, while the Titan Halo TEM provides high-quality optical performance with enhanced flexibility for multi-scale applications in life and biomaterials sciences. Peter Fruhstorfer, Vice President and General Manager of Life Sciences for FEI said, "To analyze the 3D structure of molecules and molecular complexes, structural biologists typically use applications like electron tomography, where contrast enhancement is of great importance. The new phase plate solution extends the limits of these applications to enable new biological insights. We expect it will help our customers deliver results at the forefront of discovery." The full research reports on FEI are available to download free of charge at:
http://www.analystsreview.com/Aug-01-2014/FEIC/report.pdf
Cepheid Research Reports
On July 17, 2014, Cepheid reported its Q2 2014 financial results with revenues of $116.5 million, up 21.4% YoY. Net loss for the quarter was $9.8 million, or $0.14 per diluted share compared to a net loss of $6.6 million, or $0.10 per diluted share in Q2 2013. During the quarter, the Company completed the installation of 158 GeneXpert systems in its commercial Clinical business and placed 926 GeneXpert systems as part of its High Burden Developing Country (HBDC) program. John Bishop, Cepheid's Chairman and CEO said, "With continuing adoption of our GeneXpert system in both commercial and emerging HBDC geographies, we placed a record 1,084 GeneXpert systems in the quarter, more systems than we placed in all of 2012." The Company anticipates full year 2014 revenues to be the range of $452 million to $461 million. The full research reports on Cepheid are available to download free of charge at:
http://www.analystsreview.com/Aug-01-2014/CPHD/report.pdf
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
EDITOR'S NOTES:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
